Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to identify the opioid-sparing effects, and pain-reduction
potential of low dose, sub-dissociative ketamine on patients undergoing thoracic endovascular
aortic repair (TEVAR) procedures receiving naloxone continuous infusion (NCI).